*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
C61 - Malignant neoplasm of prostate - as a primary diagnosis code | C61 - Malignant neoplasm of prostate - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 5.0 | |
Readmission Rate (%) | 20.1 | |
Unplanned Readmission Rate (%) | 6.14 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 723: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 713: TRANSURETHRAL PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 41,026 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 39,353 | ||||
DRG Share of Total Hospitalizations | 0.12 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 60.77 | ||||
Avg LOS at DRG | 1.47 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 1.42 | ||||
Readmission Rate at DRG | 4.09 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 4.03 | ||||
Unplanned Readmission Rate at DRG | 3.2 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 3.16 | ||||
Total Medicare payments at DRG | $301,816,837 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $288,583,905 | ||||
Total Medicare payment per Day at DRG | $5,001 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $5,148 | ||||
Total Medicare payment per Hospitalization at DRG | $7,357 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $7,333 | ||||
Total Medicare Charges at DRG | $2,330,115,586 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $2,242,714,882 | ||||
Avg Charges at DRG | $56,796 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $56,990 | ||||
Mortality Rate at DRG | NA | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
SNF Discharge Rate at DRG | 0.28 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 0.21 | ||||
Home Discharge Rate at DRG | 95.0 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 95.27 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 715: OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 714: TRANSURETHRAL PROSTATECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 716: OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 724: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,262 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 1,170 | ||||
DRG Share of Total Hospitalizations | 0.0 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 1.81 | ||||
Avg LOS at DRG | 6.97 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 6.98 | ||||
Readmission Rate at DRG | 22.57 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 22.81 | ||||
Unplanned Readmission Rate at DRG | 16.69 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 17.38 | ||||
Total Medicare payments at DRG | $17,375,457 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $16,053,582 | ||||
Total Medicare payment per Day at DRG | $1,977 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $1,967 | ||||
Total Medicare payment per Hospitalization at DRG | $13,768 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $13,721 | ||||
Total Medicare Charges at DRG | $95,143,894 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $88,614,680 | ||||
Avg Charges at DRG | $75,391 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $75,739 | ||||
Mortality Rate at DRG | 2.46 | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | 2.48 | ||||
SNF Discharge Rate at DRG | 19.57 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 19.83 | ||||
Home Discharge Rate at DRG | 47.94 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 47.95 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 989: NON-EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 710: PENIS PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 52,726 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 138 | ||||
DRG Share of Total Hospitalizations | 0.16 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 0.21 | ||||
Avg LOS at DRG | 6.68 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 6.64 | ||||
Readmission Rate at DRG | 24.76 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 17.78 | ||||
Unplanned Readmission Rate at DRG | 14.45 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 14.81 | ||||
Total Medicare payments at DRG | $902,862,104 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $2,395,615 | ||||
Total Medicare payment per Day at DRG | $2,565 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $2,615 | ||||
Total Medicare payment per Hospitalization at DRG | $17,124 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $17,360 | ||||
Total Medicare Charges at DRG | $4,216,562,728 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $9,490,745 | ||||
Avg Charges at DRG | $79,971 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $68,774 | ||||
Mortality Rate at DRG | 0.83 | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
SNF Discharge Rate at DRG | 22.41 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 17.39 | ||||
Home Discharge Rate at DRG | 43.51 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 47.1 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 983: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 709: PENIS PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 11,723 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 45 | ||||
DRG Share of Total Hospitalizations | 0.04 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 0.07 | ||||
Avg LOS at DRG | 3.14 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 1.51 | ||||
Readmission Rate at DRG | 12.89 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
Unplanned Readmission Rate at DRG | 7.1 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
Total Medicare payments at DRG | $122,697,695 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $442,173 | ||||
Total Medicare payment per Day at DRG | $3,328 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $6,503 | ||||
Total Medicare payment per Hospitalization at DRG | $10,466 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $9,826 | ||||
Total Medicare Charges at DRG | $633,485,759 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $2,351,000 | ||||
Avg Charges at DRG | $54,038 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $52,244 | ||||
Mortality Rate at DRG | 0.25 | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
SNF Discharge Rate at DRG | 9.06 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
Home Discharge Rate at DRG | 70.16 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 97.78 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 798 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 690 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 666 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. VIPUL R PATEL | 410 CELEBRATION PL | CELEBRATION | FL | 34747 | 664 |
Dr. ASHUTOSH TEWARI | 525 E 68TH ST - STARR 900 | NEW YORK | NY | 10021 | 284 |
Dr. RONNEY ABAZA | 7450 HOSPITAL DR | DUBLIN | OH | 43016 | 214 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. VIPUL R PATEL | 410 CELEBRATION PL | CELEBRATION | FL | 34747 | 634 |
Dr. ASHUTOSH TEWARI | 525 E 68TH ST - STARR 900 | NEW YORK | NY | 10021 | 287 |
Dr. DAVID I LEE | 51 N 39TH ST | PHILADELPHIA | PA | 19104 | 216 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 41,026 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 39,396 | ||||
DRG Share of Total Hospitalizations | 0.12 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 13.25 | ||||
Avg LOS at DRG | 1.47 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 1.43 | ||||
Readmission Rate at DRG | 4.09 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 4.03 | ||||
Unplanned Readmission Rate at DRG | 3.2 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 3.16 | ||||
Total Medicare payments at DRG | $301,816,837 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $288,883,355 | ||||
Total Medicare payment per Day at DRG | $5,001 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $5,145 | ||||
Total Medicare payment per Hospitalization at DRG | $7,357 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $7,333 | ||||
Total Medicare Charges at DRG | $2,330,115,586 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $2,245,617,147 | ||||
Avg Charges at DRG | $56,796 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $57,001 | ||||
Mortality Rate at DRG | NA | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | NA | ||||
SNF Discharge Rate at DRG | 0.28 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 0.22 | ||||
Home Discharge Rate at DRG | 95.0 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 95.26 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 723: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,013,774 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 5,832 | ||||
DRG Share of Total Hospitalizations | 3.08 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 1.96 | ||||
Avg LOS at DRG | 5.34 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 5.58 | ||||
Readmission Rate at DRG | 28.25 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 26.39 | ||||
Unplanned Readmission Rate at DRG | 21.93 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 20.69 | ||||
Total Medicare payments at DRG | $9,469,067,156 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $55,679,568 | ||||
Total Medicare payment per Day at DRG | $1,751 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $1,712 | ||||
Total Medicare payment per Hospitalization at DRG | $9,340 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $9,547 | ||||
Total Medicare Charges at DRG | $43,343,716,813 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $266,452,775 | ||||
Avg Charges at DRG | $42,755 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $45,688 | ||||
Mortality Rate at DRG | 3.72 | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | 5.61 | ||||
SNF Discharge Rate at DRG | 20.84 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 21.3 | ||||
Home Discharge Rate at DRG | 37.68 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 34.38 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 543: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 105,234 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 4,025 | ||||
DRG Share of Total Hospitalizations | 0.32 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 1.35 | ||||
Avg LOS at DRG | 4.18 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 4.04 | ||||
Readmission Rate at DRG | 24.62 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 27.19 | ||||
Unplanned Readmission Rate at DRG | 17.79 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 21.3 | ||||
Total Medicare payments at DRG | $723,145,698 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $27,301,720 | ||||
Total Medicare payment per Day at DRG | $1,644 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $1,680 | ||||
Total Medicare payment per Hospitalization at DRG | $6,872 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $6,783 | ||||
Total Medicare Charges at DRG | $3,557,869,598 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $125,975,696 | ||||
Avg Charges at DRG | $33,809 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $31,298 | ||||
Mortality Rate at DRG | 0.27 | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | 0.47 | ||||
SNF Discharge Rate at DRG | 20.33 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 19.6 | ||||
Home Discharge Rate at DRG | 48.52 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 43.38 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 160,950 | ||||
Total Hospitalizations with ICD C61 - Malignant neoplasm of prostate | 2,990 | ||||
DRG Share of Total Hospitalizations | 0.49 | ||||
% of Total ICD C61 - Malignant neoplasm of prostate in DRG | 1.01 | ||||
Avg LOS at DRG | 4.98 | ||||
Avg LOS with ICD C61 - Malignant neoplasm of prostate | 4.62 | ||||
Readmission Rate at DRG | 20.85 | ||||
Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 25.22 | ||||
Unplanned Readmission Rate at DRG | 13.4 | ||||
Unplanned Readmission Rate with ICD C61 - Malignant neoplasm of prostate | 18.98 | ||||
Total Medicare payments at DRG | $1,184,949,733 | ||||
Total Medicare payments with ICD C61 - Malignant neoplasm of prostate | $19,827,120 | ||||
Total Medicare payment per Day at DRG | $1,477 | ||||
Total Medicare payment per Day with ICD C61 - Malignant neoplasm of prostate | $1,437 | ||||
Total Medicare payment per Hospitalization at DRG | $7,362 | ||||
Total Medicare payment per Hospitalization with ICD C61 - Malignant neoplasm of prostate | $6,631 | ||||
Total Medicare Charges at DRG | $4,222,078,897 | ||||
Total Medicare Charges with ICD C61 - Malignant neoplasm of prostate | $82,750,388 | ||||
Avg Charges at DRG | $26,232 | ||||
Avg Charges with ICD C61 - Malignant neoplasm of prostate | $27,676 | ||||
Mortality Rate at DRG | 0.67 | ||||
Mortality Rate with ICD C61 - Malignant neoplasm of prostate | 1.91 | ||||
SNF Discharge Rate at DRG | 22.29 | ||||
SNF Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 18.63 | ||||
Home Discharge Rate at DRG | 35.46 | ||||
Home Discharge Rate with ICD C61 - Malignant neoplasm of prostate | 37.56 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 1,607 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 1,566 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 1,411 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. VIPUL R PATEL | 410 CELEBRATION PL | CELEBRATION | FL | 34747 | 666 |
Dr. ASHUTOSH TEWARI | 525 E 68TH ST - STARR 900 | NEW YORK | NY | 10021 | 286 |
Dr. JOHN W. DAVIS | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 216 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. VIPUL R PATEL | 410 CELEBRATION PL | CELEBRATION | FL | 34747 | 645 |
Dr. ASHUTOSH TEWARI | 525 E 68TH ST - STARR 900 | NEW YORK | NY | 10021 | 291 |
Dr. JOHN W. DAVIS | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 220 |